NYX: Key Regulator of Retinal Development and Maintenance (G60506)

Target Name: NYX

NCBI ID: G60506

Content of Review Report on NYX Target / Biomarker

NYX

NYX: Key Regulator of Retinal Development and Maintenance

NYX (Nyctalopin, transcript variant 1) is a protein that is expressed in the retina of the eye. It is a transcription factor that plays a role in the development and maintenance of the retina, and it is also involved in the regulation of vision.

NYX is a key regulator of the neural transition, which is the process by which the retina develops its unique structure and function. During the neural transition, NYX helps to ensure that the retina is properly organized and that it is able to function properly.

One of the key functions of NYX is its role in the development of the optic nerve, which is the nerve that carries visual information from the eye to the brain. During the neural transition, NYX helps to ensure that the optic nerve is properly formed and that it is able to function properly.

NYX is also involved in the regulation of the blood flow to the retina. This is important for ensuring that the retina is able to receive the necessary oxygen and nutrients, and for preventing damage to the retina.

In addition to its role in the neural transition, NYX is also involved in the regulation of gene expression. This is important for ensuring that the retina is able to produce the necessary proteins, which are essential for its proper function.

NYX is also a potential drug target, as it has been shown to be involved in a number of important processes in the eye. For example, studies have shown that NYX is involved in the regulation of cell death, which is important for preventing the progression of diseases such as cancer.

In addition, NYX is also shown to be involved in the regulation of the blood pressure, which is important for maintaining proper blood flow to the body.

Overall, NYX is a protein that plays a critical role in the development and maintenance of the retina. Its functions include ensuring the proper formation of the optic nerve, regulating blood flow to the retina, and regulating gene expression. As a result, it is a potential drug target for the development of new treatments for a number of eye and brain diseases.

Protein Name: Nyctalopin

The "NYX Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about NYX comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets